Healthcare Services

Acute Pharyngitis Market Global Report 2026 Market Size Outlook and Demand Growth Across 2026–2030

March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Acute Pharyngitis Market During The Forecast Period 2026–2030?

The acute pharyngitis market size has experienced significant growth in recent years. This market is projected to expand from $2.89 billion in 2025 to $3.13 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. Historically, this expansion has been driven by factors such as the high prevalence of viral and bacterial pharyngitis, limited awareness regarding treatment options, the expansion of healthcare infrastructure, an increase in outpatient visits, and the growing availability of pharmaceuticals.

The acute pharyngitis market is anticipated to experience robust expansion over the next few years. It is projected to achieve a value of $4.25 billion by 2030, reflecting a compound annual growth rate (CAGR) of 8.0%. This growth during the forecast period is driven by factors such as the development of innovative antivirals and antibiotics, the increasing adoption of telemedicine, the expansion of online pharmacy platforms, a rising awareness of herbal and alternative remedies, and the broader availability of homecare and specialty care services. Significant trends expected in this period include a greater utilization of antibiotics and antivirals for acute pharyngitis, the growing preference for over-the-counter medications, an increasing interest in herbal and alternative therapies, the expansion of both hospital and homecare treatment options, and an emphasis on anti-inflammatory and corticosteroid-based treatments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21082&type=smp

Which Economic Or Industry Drivers Are Impacting The Acute Pharyngitis Market?

The increasing incidence of influenza is projected to boost the acute pharyngitis market’s expansion. This viral infection, spread via respiratory droplets from coughs, sneezes, or contaminated surfaces, sees its prevalence climb due to elements like seasonal changes, low vaccination uptake, greater human movement, viral evolution, and diminished immunity in some groups. Treatment for acute pharyngitis aids influenza sufferers by easing throat inflammation and discomfort, reducing difficulty in swallowing, averting subsequent bacterial infections, and facilitating general recuperation. When combined with antiviral drugs, sufficient hydration, and rest, it significantly improves the body’s capacity to combat the influenza virus. For example, data from the Centers for Disease Control and Prevention, a US-based government agency, indicated that by February 2025, 31.6% of clinical lab tests confirmed positive for influenza, an increase from 29.4% the week prior and 18.6% at the beginning of the year. Consequently, the rising prevalence of influenza is a key factor propelling the expansion of the acute pharyngitis market.

What Market Segments Are Evaluated Within The Acute Pharyngitis Market?

The acute pharyngitis market covered in this report is segmented –

1) By Treatment: Antibiotics, Antivirals, Over-the-Counter (OTC) Medications, Corticosteroids And Anti-inflammatory Drugs

2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

3) By End-User: Hospitals, Homecare, Speciality Centres, Other End Users

Subsegments:

1) By Antibiotics: Penicillins, Cephalosporins, Macrolides

2) By Antivirals: Neuraminidase Inhibitors, Nucleoside Analogs

3) By Over-the-Counter (OTC) Medications: Analgesics, Throat Lozenges, Cough Syrups

4) By Corticosteroids And Anti-inflammatory Drugs: Glucocorticoids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

What Industry Trends Are Redefining The Acute Pharyngitis Market?

Leading companies in the acute pharyngitis market are concentrating on developing advanced solutions, such as multiplex syndromic POC testing, to enhance diagnostic speed, improve accuracy, and facilitate pathogen-specific treatment decisions. Multiplex POC testing represents a technological approach capable of detecting multiple pathogens from a single sample swiftly, thereby enabling clinicians to differentiate between viral and bacterial infections and reduce unnecessary antibiotic use. For instance, in June 2024, bioMérieux, a France-based medical equipment manufacturer, obtained FDA Special 510(k) clearance and a CLIA waiver for its BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel Mini, which identifies common viral causes of sore throat as well as Group A Streptococcus from a single throat or nasopharyngeal swab in approximately 15 minutes. This test operates on the BIOFIRE SPOTFIRE platform, allowing clinicians to select a small or larger multiplex respiratory panel depending on their specific needs and setting. The Mini panel displays strong sensitivity for four respiratory viruses, including rhinovirus and influenza, and for Streptococcus A, aiding clinicians in making rapid, targeted treatment choices.

Who Are The Top Market Participants Influencing The Acute Pharyngitis Market?

Major companies operating in the acute pharyngitis market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, F. Hoffmann La Roche AG, Abbott Laboratories, Bayer AG, Eli Lilly and Company, Bristol Myers Squibb Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Hikma Pharmaceuticals PLC, Lupin Limited, Alkem Laboratories Ltd., Cipla Limited, Sun Pharmaceutical Industries Limited

Read the full acute pharyngitis market report here:

https://www.thebusinessresearchcompany.com/report/acute-pharyngitis-global-market-report

What Are The Top-Performing Regions Within The Acute Pharyngitis Market?

North America was the largest region in the acute pharyngitis market in 2025. The regions covered in the acute pharyngitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Acute Pharyngitis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21082&type=smp

Browse Through More Reports Similar to the Global Acute Pharyngitis Market 2026, By The Business Research Company

severe acute respiratory syndrome treatment global market report

https://www.thebusinessresearchcompany.com/report/severe-acute-respiratory-syndrome-treatment-global-market-report

esophageal dysphagia global market report

https://www.thebusinessresearchcompany.com/report/esophageal-dysphagia-global-market-report

acute bacterial skin and skin structure infections global market report

https://www.thebusinessresearchcompany.com/report/acute-bacterial-skin-and-skin-structure-infections-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795